PIANTONI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 2.406
AS - Asia 1.291
EU - Europa 1.223
SA - Sud America 227
AF - Africa 36
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.191
Nazione #
US - Stati Uniti d'America 2.354
SG - Singapore 499
CN - Cina 335
IT - Italia 274
DE - Germania 217
BR - Brasile 191
HK - Hong Kong 150
PL - Polonia 139
FI - Finlandia 125
VN - Vietnam 96
UA - Ucraina 95
GB - Regno Unito 85
FR - Francia 76
RU - Federazione Russa 61
BD - Bangladesh 60
TR - Turchia 40
IE - Irlanda 33
SE - Svezia 32
CA - Canada 28
IN - India 22
NL - Olanda 22
MX - Messico 13
ZA - Sudafrica 13
JP - Giappone 12
AR - Argentina 11
IQ - Iraq 11
ES - Italia 10
AT - Austria 9
PK - Pakistan 9
CO - Colombia 8
SA - Arabia Saudita 8
ID - Indonesia 7
MK - Macedonia 7
BE - Belgio 6
CZ - Repubblica Ceca 6
GR - Grecia 6
KR - Corea 6
PH - Filippine 6
AU - Australia 5
MA - Marocco 5
TN - Tunisia 5
AZ - Azerbaigian 4
EG - Egitto 4
JO - Giordania 4
KE - Kenya 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
LT - Lituania 3
PY - Paraguay 3
VE - Venezuela 3
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
UY - Uruguay 2
UZ - Uzbekistan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CY - Cipro 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UG - Uganda 1
Totale 5.191
Città #
Ashburn 304
Singapore 285
Fairfield 222
San Jose 167
Hong Kong 148
Warsaw 136
Woodbridge 118
New York 102
Chandler 91
Beijing 90
Seattle 90
Houston 89
The Dalles 85
Cambridge 84
Helsinki 84
Jacksonville 80
Wilmington 76
Dallas 70
Munich 63
Princeton 58
Los Angeles 51
Ann Arbor 44
Brescia 38
Lauterbourg 34
Turku 33
Dublin 32
Ho Chi Minh City 32
Istanbul 30
Milan 28
Hanoi 24
São Paulo 23
San Francisco 22
Buffalo 19
Council Bluffs 19
Redondo Beach 19
London 16
Moscow 16
Shanghai 16
Des Moines 15
Santa Clara 15
Orem 14
Chicago 13
San Diego 13
Bergamo 12
Nanjing 12
Denver 11
Johannesburg 11
Rome 11
Brooklyn 10
Changsha 10
Nuremberg 10
Tokyo 10
Montreal 9
Nanchang 8
Salò 8
Stockholm 8
Amsterdam 7
Atlanta 7
Chennai 7
Dhaka 7
Vienna 7
Belo Horizonte 6
Boardman 6
Brussels 6
Ferrara 6
Frankfurt am Main 6
Shenyang 6
Turin 6
Vancouver 6
Albuquerque 5
Bogotá 5
Columbus 5
Erbil 5
Haikou 5
Jiaxing 5
Lappeenranta 5
Mexico City 5
Ningbo 5
Nürnberg 5
Paris 5
Rio de Janeiro 5
Amman 4
Ankara 4
Baku 4
Bosio 4
Cairo 4
Dong Ket 4
Dosso 4
Guangzhou 4
Hangzhou 4
Hebei 4
Jakarta 4
Jinan 4
Nairobi 4
Ninh Bình 4
Olomouc 4
Osasco 4
Redwood City 4
Rivoli 4
Seoul 4
Totale 3.357
Nome #
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 340
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 215
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 195
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 187
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 187
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 180
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 180
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 174
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 174
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 171
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 169
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 168
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 157
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 151
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al 150
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 138
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 137
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis 132
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker 130
Pathophysiological role and therapeutic implications of vitamin d in autoimmunity: Focus on chronic autoimmune diseases 121
A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis 118
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 117
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al 117
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system 116
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. 115
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies 115
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 112
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept 94
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment 93
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 92
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 91
Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis 90
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 90
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 83
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases 78
Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases 68
Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada 67
Editorial: Into the heart of systemic autoimmune diseases. 65
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study 56
Diagnostic performance of particle-based multi-analyte technology compared to indirect immunofluorescence in screening for anti-nuclear antibodies in patients with autoimmune rheumatic diseases 16
Multicenter study to improve clinical interpretation of anticardiolipin and anti-β2-glycoprotein I antibody test results for diagnosis of antiphospholipid syndrome 13
Potential role of the spleen in the development of arterial hypertension in humans 12
Totale 5.274
Categoria #
all - tutte 27.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.206


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022321 26 24 9 29 3 26 14 17 15 51 44 63
2022/2023250 33 8 7 19 27 62 3 28 46 0 7 10
2023/2024419 23 11 57 44 22 82 12 63 60 6 2 37
2024/2025933 9 19 21 110 71 83 57 54 96 94 181 138
2025/20261.933 176 229 145 235 197 153 297 85 97 175 71 73
2026/202712 12 0 0 0 0 0 0 0 0 0 0 0
Totale 5.274